期刊論文| 1. | (2004)。Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock。Crit Care Med，32，852-873。   |
| 2. | 方麗華(20050000)。戰勝敗血症臨床指引(藥物部份)。中化藥訊，66(3)，5-11。 延伸查詢 |
| 3. | Annane, D.、Bellissant, E.(2005)。Septic shock。Lancet，365，63-78。 |
| 4. | American College of Chest Physicians/Society of Critical Care Medicine consensus conference committee(1992)。Definitions for sepsis and organ failure and guidelines for the use of innovative therapy in sepsis。Crit Care Med，20，864-874。 |
| 5. | Levy, M. M.、Fink, M. P.、Marshall, J. C.、Abraham, E.、Angus, D.、Cook, D.、Ramsay, G.(2001)。SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definition Conference。Crit Care Med，31(4)，1250-1256。 |
| 6. | Annane, D.、Aegerter, P.(2003)。Current epidemiology of septic shock: the CUB-Rea Network。Am J Respir Crit Care Med，168，165-172。 |
| 7. | 周志道、尹彙文、蔣台舟、周少鈞、秦維廉、劉乂鳴、徐小安(20040000)。敗血症病人早期血流動力支持療法的最新臨床發展。中華民國重症醫學雜誌，6(3)，220-233。 延伸查詢 |
| 8. | River, E.、Nguyen, B.、Havstad, S.(2001)。Early goal-directed therapy in the treatment of severe sepsis and septic shock。N Engl J. Med，345，1368-1377。 |
| 9. | Hollenberg, S. M.、Ahrens, T. S.、Annane, D.(2004)。Practice parameter for hemodynamic support of sepsis in adult patients。Crit Care Med，32(9)，1928-1948。 |
| 10. | Finfer, S.、Bellomo, R.、Boyce, N.(2004)。A comparison of albumin and saline for fluid resucutation in the intensive care unit。N Engl J Med，350，2247-2256。 |
| 11. | Bellomo, R.、Chapman, M.、Finfer, S.(2000)。Low dose dopamine in patient with early renal dysfunction:A placebo-controlled randomized trial (ANZICS) Clinical Trials Group。Lancet，356，2139-2143。 |
| 12. | Martin, C.、Parazian, L.、Perrin, G.(1993)。Norepinephrine or dopamine for the treatment of hyperdynamic septic shock。Chest，103，1826-1831。 |
| 13. | Umino, T.、Kusano, E.、Muto, S.。AVP inhibits LPS and IL-lp stimulated NO and c GMP via VI receptor in cultured rat mesangial cells。Am J Physiol，276，F433-F441。 |
| 14. | Wakatsuki, T.、Nakaya, Y.、Inoue, I.(1992)。Vasopressin modulates K+-channel activities of cultured smooth muscle cells from porcine coronary artery。Am J Physiol，263，H491-H496。 |
| 15. | Landry, D. W.、Oliver, J. A.(1992)。The ATP-sensitive K+ channels mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog。J Clin Invest，89，2071-2074。 |
| 16. | Kennedy, B.、Ziegler, M. G.(1991)。Cardiac epinephrine synthesis: Regulation by a glucocorticoid。Circulation，84，891-895。 |
| 17. | Failey, J. W.、Westfall, T. C.(1978)。Effects of adrenalectomy and adrenal steroids on norepithesis and monoamine oxidase activity。Eur J Pharmacol，48，383-391。 |
| 18. | Sakaue, M.、Hoffman, B. B.(1991)。Glucocorticoids induce transcription and expression of the alpha IB adrenergic receptor gene in DTT1MF-2 smooth muscle cell。J Clin Invest，88，385-389。 |
| 19. | Haigh, R. M.、Jones, C. T.(1990)。Effectof glucocorticoids on alpha 1-adrenergic receptor binding in rat vascular smooth muscle。J Mol Endocrinol，5，41-48。 |
| 20. | Sato, A.、Suzuki, H.、Murakami, M.(1994)。Glucocorticoid increases angiotensin II type 1 receptor and its gene expression。Hypertension，23，25-30。 |
| 21. | Scheuer, D. A.、Bechtold, A. G.(2001)。Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure。Am J PhysiolRegul Integr Comp Physiol，280，1719-1726。 |
| 22. | Annane, D.、Bellissant, E.、Sebille, V.(1998)。Impaired pressor sensitivity to noradrenaline in septic shock paitents with and without impaired adrenal function reserve。Br J Clin Pharmacol，46，589-597。 |
| 23. | Annane, D.、Sebille, V.、Charpentier, C.(2002)。Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock。JAMA，288，862-871。 |
| 24. | Annane, D.、Bellissant, E.、Bollaert, P.、Briegel, J.、Keh, D.、Kupfer, Y.(2004)。Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis。BMJ，329(7464)，480-488。 |
| 25. | 葉春長、吳慶堂、汪志雄(20021000)。血管加壓素在重症病人之應用。中華民國重症醫學雜誌，4(4)，251-260。 延伸查詢 |